Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema
- 1 September 2008
- journal article
- clinical trial
- Published by Wiley in Dermatologic Therapy
- Vol. 21 (s2) , S35-S38
Abstract
Triclosan is a lypophilic chlorophenol biocide with broad-spectrum antibacterial and antifungal activity. Triclosan-based topical products have been shown to be tolerated and beneficial in atopic dermatitis. The aim of this study was to evaluate the sensitizing potential of triclosan and triclosan-based creams in patients affected by eczematous dermatitis. Two hundred and seventy-five patients affected by chronic eczema (allergic contact dermatitis, irritant contact dermatitis, atopic eczema, nummular eczema, stasis dermatitis) were patch tested with standard patch test series as well as triclosan and triclosan-based products. Standard patch test series resulted positive in 164 patients (61%), with nickel sulfate, house dust mites, fragrance mix, propolis, thimerosal, myroxylon pereira, potassium dichromate, wool alcohols, and p-phenylenediamine the most common sensitizing haptens. Only two patients developed positive reactions to triclosan (0.7%) and four (1.4%) to triclosan-based products. The present study's results confirm that triclosan is well tolerated and has a very low sensitizing potential even in high-risk patients affected by eczema.Keywords
This publication has 14 references indexed in Scilit:
- TriclosanDermatitis®, 2006
- Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolatesJournal of Applied Microbiology, 2006
- Elimination of a Community-Acquired Methicillin-Resistant Staphylococcus aureus Infection in a Nurse With Atopic DermatitisArchives of Dermatology, 2005
- Epidemiologic Background of Hand Hygiene and Evaluation of the Most Important Agents for Scrubs and RubsClinical Microbiology Reviews, 2004
- Allergic contact dermatitis from triclosan in antibacterial handwashesContact Dermatitis, 2001
- Triclosan targets lipid synthesisNature, 1998
- Topical triclosan treatment of atopic dermatitisJournal of Allergy and Clinical Immunology, 1997
- Triclosan: Applications and safetyAmerican Journal of Infection Control, 1996
- Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nurseryAmerican Journal of Infection Control, 1995
- Frequency of sensitization to 13 common preservatives in Switzerland*Contact Dermatitis, 1994